[Epidemiology of venous thrombosis].
Venous thrombo-embolic disease (VTE) is a frequent pathology, responsible for around 10,000 deaths each year in France. Post-thrombotic sequellae is also a main problem related to the disease. The epidemiology of acquired and genetic risk factors of VTE is better understood and has allowed to show that in many cases it is a multifactorial disease. The association of several environmental or genetic and their analysis in the physiopathology of the disease and in the risk of recurrency is important in order to allow a better prevention of the disease and of its recurrencies.
Emmerich
Joseph
J
Service de Médecine Vasculaire-HEGP et Unité INSERM U428, 20-40 rue Leblanc-75908 Paris. joseph.emmerich@egp.ap-hop-paris.fr
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D001779:Blood Coagulation Factors / Q000235:genetics; D003276:Contraceptives, Oral / Q000009:adverse effects; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D007103:Immobilization / Q000009:adverse effects; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009154:Mutation; D011110:Polymorphism, Genetic; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000453:epidemiology; D011655:Pulmonary Embolism / Q000453:epidemiology / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012307:Risk Factors; D014195:Travel; D020246:Venous Thrombosis / Q000139:chemically induced / Q000453:epidemiology* / Q000235:genetics / Q000517:prevention & control
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D003276:Contraceptives, Oral